Announcements

Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
Reagan-Udall Foundation for the FDA Announces New Board Chair; Welcomes New Board Member
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
Read More
More Announcements

Coverage

Legis1: FDA Faces Staffing Crisis Threatening U.S. Drug Innovation
The FDA biomedical innovation hearing featured five witnesses: Susan Winckler from the Reagan-Udall Foundation for the FDA, Aaron J. Kowalski from Breakthrough T1D, Dr. Thomas Hwang from Brigham and Women's Hospital and Harvard Medical School, Dr.…
Read More
Alston & Bird: Health Care Week in Review: July 17, 2026
On July 15, 2026, the House Energy and Commerce Committee held a hearing entitled, Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
Read More
FDA: Psychedelic Drugs
FDA is supporting the development of psychedelic drugs, including new treatments for serious mental health conditions.
Read More
More Coverage